Prostate Cancer News

FDA Approves Xtandi for Treatment of Castration-resistant Prostate Cancer
On July 13, 2018, the Food and Drug Administration approved Xtandi (enzalutamide) for patients with castration-resistant prostate cancer (CRPC).  This approval broadens the indicated patient population... Continue Reading

Immediate vs Delayed Androgen Deprivation Therapy in Prostate Cancer
CancerConnect News: There is an ongoing discussion about the optimal timing of using androgen deprivation therapy (ADT) in men with prostate cancer who have relapsed based on a rising prostate-specific... Continue Reading

More Cancer Updates

News and Events

Seventh Annual Prostate Cancer Awareness Golf Tournament
July 10, 2018 at 9:00 AM to benefit The Prostate Cancer Educational Institute of Virginia, 501-c-3
Click here to learn more

Our support group meets monthly on the first Wednesday of each month. Please click here to see our informational flyer and meeting dates. All are welcome to join our informative group.